XSHE
002044
Market cap2.64bUSD
Oct 09, Last price
4.90CNY
1D
8.41%
1Q
5.60%
Jan 2017
-55.37%
IPO
-31.47%
Name
Meinian Onehealth Healthcare Holdings Co Ltd
Chart & performance
P/E
67.22
P/S
1.85
EPS
0.07
Div yield, %
0.30%
Shrs. gr., 5y
0.94%
Rev. gr., 5y
5.71%
Revenues
10.36b
-3.20%
Net income
285m
+1.09%
CFO
1.80b
+8.31%
Dividend
Jul 13, 20260.009 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Meinian Onehealth Healthcare Holdings Co., Ltd. delivers a comprehensive suite of health services, encompassing medical check-ups and professional health consultations. Their offerings further include specialized preventative care, robust health protection programs, and personalized medical concierge assistance. The company's significant presence is marked by approximately 605 medical examination centers, distributed across roughly 308 cities throughout China. Established in 2001, its corporate headquarters are located in Shanghai, China.
Key people
Tao Xu
President, Director · since 2022
Lingchang Hou
Chief Financial Officer, Vice President · since 2024
Lin Lin
Chief Operating Officer, Senior Vice President, General Manager- Beijing and Northern Region · since 2022
Xiaoxiao Wan
Vice President, Secretary of the Board · since 2023
Meiling Guo
Vice Chairman of the Board · since 2015
Xiaojun Wang
Director · since 2021
Ce Yang
Director · since 2022
Executive Chairman of the Board · since 2025
Chao Zhu
Director · since 2022
Haitong Wang
Independent Director · since 2021
Wei Wang
Independent Director · since 2024
Xiqiang Zhang
Independent Director · since 2024
Headquarters & legal address
江苏南通市人民东路218号
南通市, JS 100000
CN
南通市, JS 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||